Standard Therapies For Pulmon... Health Article

Summary

After half a century of clinical experience and research, PAH management remains a challenge. Currently, data to support the use of standard PAH therapies (eg, oxygen supplementation, diuretics, digoxin, anticoagulation, and CCBs) are mostly retrospective, uncontrolled prospective, or derived from other diseases with similar but not identical manifestations. In the absence of any further prospective, controlled studies, it is reasonable to use these therapies when they are tolerated. When these therapies are poorly tolerated, however, the threshold for discontinuation should be low.

Related Articles

Hypertension
From MDConsult Clinical Topic Tour , a patient information series

Arterial Hypertension
From Cecil Textbook of Medicine , a medical textbook

Hypertension
From Primary Care: Clinics in Office Practice , a professional medical journal